These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21239876)

  • 1. The emerging role of maternal phosphatidylinositol 3 kinase (PI3K) signaling in manipulating mammalian preimplantation embryogenesis.
    Zheng W; Liu K
    Cell Cycle; 2011 Jan; 10(2):178-9. PubMed ID: 21239876
    [No Abstract]   [Full Text] [Related]  

  • 2. Maternal phosphatidylinositol 3-kinase signalling is crucial for embryonic genome activation and preimplantation embryogenesis.
    Zheng W; Gorre N; Shen Y; Noda T; Ogawa W; Lundin E; Liu K
    EMBO Rep; 2010 Nov; 11(11):890-5. PubMed ID: 20930845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone modulation of EGF-induced PI3K-Akt pathway in mice liver.
    Díaz ME; González L; Miquet JG; Martínez CS; Sotelo AI; Bartke A; Turyn D
    Cell Signal; 2012 Feb; 24(2):514-523. PubMed ID: 22019461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast.
    Rodríguez-Escudero I; Roelants FM; Thorner J; Nombela C; Molina M; Cid VJ
    Biochem J; 2005 Sep; 390(Pt 2):613-23. PubMed ID: 15913452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. F-box and leucine-rich repeat protein 5 promotes colon cancer progression by modulating PTEN/PI3K/AKT signaling pathway.
    Yao H; Su S; Xia D; Wang M; Li Z; Chen W; Ren L; Xu L
    Biomed Pharmacother; 2018 Nov; 107():1712-1719. PubMed ID: 30257389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striking the balance between PTEN and PDK1: it all depends on the cell context.
    Iwanami A; Cloughesy TF; Mischel PS
    Genes Dev; 2009 Aug; 23(15):1699-704. PubMed ID: 19651981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of PTEN stability and activity by Plk3.
    Xu D; Yao Y; Jiang X; Lu L; Dai W
    J Biol Chem; 2010 Dec; 285(51):39935-42. PubMed ID: 20940307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Tyroserleutide on phosphatidylinositol 3'-kinase/AKT pathway in human hepatocellular carcinoma cell.
    Fu Z; Ren L; Wei H; Lv J; Che X; Zhu Z; Jia J; Wang L; Lin G; Lu R; Yao Z
    J Drug Target; 2014 Feb; 22(2):146-55. PubMed ID: 24147456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI3K/Akt signaling requires spatial compartmentalization in plasma membrane microdomains.
    Gao X; Lowry PR; Zhou X; Depry C; Wei Z; Wong GW; Zhang J
    Proc Natl Acad Sci U S A; 2011 Aug; 108(35):14509-14. PubMed ID: 21873248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PI3K/Akt pathway is present and functional in the preimplantation mouse embryo.
    Riley JK; Carayannopoulos MO; Wyman AH; Chi M; Ratajczak CK; Moley KH
    Dev Biol; 2005 Aug; 284(2):377-86. PubMed ID: 16005454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Role of PI3K/Akt Signaling in Oocyte Maturation and Early Embryo Development.
    Kalous J; Aleshkina D; Anger M
    Cells; 2023 Jul; 12(14):. PubMed ID: 37508495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of PI3K/PTEN Pathway Does Not Affect Catalytic Activity of PDK1 in Jurkat Cells.
    Yang KJ; Piao L; Shin S; Shin SY; Li Y; Lee H; Tran Q; Park J; Hong S; Brazil DP; Hemmings BA; Kim SH; Park J
    Anticancer Res; 2017 Oct; 37(10):5415-5423. PubMed ID: 28982851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells.
    Martinelli E; Troiani T; D'Aiuto E; Morgillo F; Vitagliano D; Capasso A; Costantino S; Ciuffreda LP; Merolla F; Vecchione L; De Vriendt V; Tejpar S; Nappi A; Sforza V; Martini G; Berrino L; De Palma R; Ciardiello F
    Int J Cancer; 2013 Nov; 133(9):2089-101. PubMed ID: 23629727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule inhibition of phosphatidylinositol-3,4,5-triphosphate (PIP3) binding to pleckstrin homology domains.
    Miao B; Skidan I; Yang J; Lugovskoy A; Reibarkh M; Long K; Brazell T; Durugkar KA; Maki J; Ramana CV; Schaffhausen B; Wagner G; Torchilin V; Yuan J; Degterev A
    Proc Natl Acad Sci U S A; 2010 Nov; 107(46):20126-31. PubMed ID: 21041639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Handicapping the race to develop inhibitors of the phosphoinositide 3-kinase/Akt/mammalian target of rapamycin pathway.
    Granville CA; Memmott RM; Gills JJ; Dennis PA
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):679-89. PubMed ID: 16467077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the signaling pathways that mediate cancer in PTEN and LKB1 double-knockout mice.
    Chen J; Zhang XD; Proud C
    Sci Signal; 2015 Sep; 8(392):pe1. PubMed ID: 26329580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pressure overload on cardioprotection via PI3K-Akt: comparison of postconditioning, insulin, and pressure unloading.
    Mozaffari MS; Liu JY; Schaffer SW
    Am J Hypertens; 2010 Jun; 23(6):668-74. PubMed ID: 20300072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathway-based identification of biomarkers for targeted therapeutics: personalized oncology with PI3K pathway inhibitors.
    Andersen JN; Sathyanarayanan S; Di Bacco A; Chi A; Zhang T; Chen AH; Dolinski B; Kraus M; Roberts B; Arthur W; Klinghoffer RA; Gargano D; Li L; Feldman I; Lynch B; Rush J; Hendrickson RC; Blume-Jensen P; Paweletz CP
    Sci Transl Med; 2010 Aug; 2(43):43ra55. PubMed ID: 20686178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the efficacy of targeting the phosphatidylinositol 3-kinase/AKT/mTOR signaling pathway in endometrial cancer.
    Bradford LS; Rauh-Hain A; Clark RM; Groeneweg JW; Zhang L; Borger D; Zukerberg LR; Growdon WB; Foster R; Rueda BR
    Gynecol Oncol; 2014 May; 133(2):346-52. PubMed ID: 24561032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3-kinase, Akt, and PTen: emerging key regulators of anti-apoptotic signaling and carcinogenesis.
    Martelli AM; Cocco L; Capitani S; Miscia S; Papa S; Manzoli FA
    Eur J Histochem; 2007; 51 Suppl 1():125-31. PubMed ID: 17703603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.